|
GB0211459D0
|
|
Plasmid stabilisation in vivo
|
|
GB0125744D0
|
|
Adenovirus-associated virus production
|
|
GB0121662D0
|
|
Improved nitroreductase
|
|
GB0120294D0
|
|
Improved nitroreductase
|
|
GB0109335D0
|
|
Improved gene expression
|
|
GB0108605D0
|
|
Improved gene expression
|
|
GB0022995D0
|
|
Polynucleotide
|
|
EP1173474A1
|
|
Membrane disruptive peptides covalently oligomerized
|
|
WO0053304A1
|
|
A vessel for mixing a cell lysate
|
|
GB0005099D0
|
|
TCF responsive elwment
|
|
GB9928303D0
|
|
A modified membrane disruptive peptide
|
|
GB9924973D0
|
|
Preparation of cellular components that are substantially free of chromosomal DNA
|
|
GB9916912D0
|
|
A modified membrane disruptive peptide
|
|
GB9909567D0
|
|
A modified membrane disruptive peptide
|
|
GB9909494D0
|
|
A plasmid
|
|
AU3434899A
|
|
Purification of cellular components that are substantially RNA free
|
|
GB9906712D0
|
|
A polynucleotide
|
|
GB9905646D0
|
|
A vessel for mixing a cell lysate
|
|
GB9903892D0
|
|
Methods and compositions for increased transfection efficiency
|
|
GB9901471D0
|
|
Selection process
|
